IR
-
6 Nov, 2024
Spago Nanomedical delårsrapport januari-september 2024
-
6 Nov, 2024
Spago Nanomedical interim report January-September 2024
-
21 Oct, 2024
Valberedning utsedd inför Spago Nanomedicals årsstämma 2025
-
21 Oct, 2024
Nomination committee appointed for Spago Nanomedical’s Annual General Meeting 2025
-
1 Oct, 2024
Spago Nanomedical i ny fas med fullt fokus på Tumorad-programmet
-
1 Oct, 2024
Spago Nanomedical in new phase with full focus on the Tumorad program
-
27 Aug, 2024
Spago Nanomedicals fas I/IIa-studie Tumorad-01 fortsätter efter framgångsrikt slutförd behandling av första patientgruppen
-
27 Aug, 2024
Spago Nanomedical’s Phase I/IIa study Tumorad-01 continues following successful treatment completion of first patient group
-
21 Aug, 2024
Spago Nanomedical delårsrapport januari-juni 2024
-
21 Aug, 2024
Spago Nanomedical interim report January-June 2024